Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1

Status

Recruiting 10Completed 6Not yet recruiting 3Active not recruiting 3Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 665Neoplasms 585Colorectal Neoplasms 291Carcinoma, Non-Small-Cell Lung 289Prostatic Neoplasms 277Lung Neoplasms 217Melanoma 159Multiple Myeloma 149Neoplasm Metastasis 145Head and Neck Neoplasms 143Pancreatic Neoplasms 139Ovarian Neoplasms 129Carcinoma, Hepatocellular 126Leukemia, Myeloid, Acute 121Brain Neoplasms 111Squamous Cell Carcinoma of Head and Neck 109Colonic Neoplasms 109Uterine Cervical Neoplasms 106Stomach Neoplasms 102Recurrence 101Lymphoma 100Glioblastoma 90Lymphoma, Non-Hodgkin 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 78Hematologic Neoplasms 78Lymphoma, Follicular 77Urinary Bladder Neoplasms 76Parkinson Disease 4, Autosomal Dominant Lewy Body 74Glioma 72Sarcoma 70

Interventions

Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Endometriosis × 1 year × Clear all
NCT04756037 2026-05-13

SERENE

Sumitomo Pharma Switzerland GmbH

Phase 3 Completed
1,164 enrolled 16 charts

Endometriosis, Leiomyoma

NCT07304245 2025-12-26

NICCHIENDO

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Completed
2,000 enrolled

Endometriosis

NCT03823833 2025-12-23

OFBOT

University Hospital, Lille

Completed
82 enrolled
Gynecologic

Dermoid Cyst, Endometriosis, Mucocele, Ovarian Cysts

NCT07210918 2025-11-24

Serum Trace Element Levels in Some Gynecological Diseases

Cumhuriyet University

Phase NA Completed
40 enrolled
Gynecologic

Endometriosis, Endometrial Neoplasms

NCT06949124 2025-09-10

A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
20 enrolled

Endometriosis, Leiomyoma

NCT06969664 2025-08-19

A Trial of SHR7280 in Healthy Subjects

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
16 enrolled

Endometriosis, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡